Thomas Bachman

Aug 04, 2015

Eppendorf announced that Thomas Bachman was appointed CEO on August 1, 2015. Bachman is taking over for Detmar Ammerman, who took on the role of CEO in addition to his responsibilities as CFO upon the departure of the previous CEO. Bachman has been a member of Eppendorf's supervisory board since 2013. Before joining Eppendorf, he held a position as president of Burker BioSpin. He has been active in the life science sector since 2005, when he managed the Tecan group, headquartered in Switzerland.

Breaking News

Thomas Bachman

Cerebral Palsy Sequencing Study Finds Clinically Actionable Alterations

Lucid Diagnostics Raises $22M in Convertible Debt Refinancing

Medicover Genetics Receives IVDR Certification for Genetic Testing Reagent Kit

Final FDA Guidance Lays Path for Drugmakers to Establish Circulating Tumor DNA as Trial Endpoint

Multi-Ancestry Study Uncovers Genetic Contributors to Progressive Eye Disease